Children's and Infants' Liquid Medicines Recalled

Not due to adverse events; includes some Tylenol, Motrin, Zyrtec, and Benadryl products
By Beth Gilbert
HealthDay Reporter

MONDAY, May 3 (HealthDay News) -- McNeil Consumer Healthcare and the U.S. Food and Drug Administration have alerted health care professionals of the voluntary recall of various over-the-counter liquid products for children and infants, including Tylenol, Motrin, Zyrtec and Benadryl products, as some of them may not meet quality standards.

According to the FDA, the recall was not issued because of reported adverse events. However, while the potential for serious adverse events is small, the agency recommends that, as a precautionary measure, these products not be administered to children. Some of the products may contain a higher concentration of active ingredient than specified, inactive ingredients that may not meet internal testing requirements, or tiny particles.

The recalled products were manufactured in the United States and distributed in the United States, Canada, Dominican Republic, Dubai, Fiji, Guam, Guatemala, Jamaica, Puerto Rico, Panama, Trinidad and Tobago, and Kuwait. The FDA recommends that health care professionals and consumers report any adverse reactions to the FDA's MedWatch Adverse Event Reporting program.

"While the potential for serious health problems is remote, Americans deserve medications that are safe, effective and of the highest quality. We are investigating the products and facilities associated with this recall and will provide updates as we learn more," FDA Commissioner of Food and Drugs, Margaret A. Hamburg, M.D., said in a statement.

More Information

Copyright © 2010 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles

What internal motivators drive RNs to pursue a BSN?
Nursing2014 , October 2014
Free access will expire on November 24, 2014.


Breast Cancer Risk Assessment in Primary Care
MCN, The American Journal of Maternal/Child Nursing, September/October 2014
Free access will expire on November 10, 2014.


Nurses spurring innovation
Nursing Management, October 2014
Free access will expire on November 10, 2014.


More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events